F S&P 500
5,217.25 +3.50 (+0.07%) F Dow Jones
39,051.00 +24.00 (+0.06%) F Nasdaq
18,209.00 +9.50 (+0.05%) E-mini Russell 2000 Index Futur
2,072.90 -3.80 (-0.18%) Petróleo
77.57 -0.81 (-1.03%) Oro
2,319.70 -4.50 (-0.19%)
Rapid Therapeutic Science Laboratories, Inc. (RTSL)
Rapid Therapeutic Science Laboratories, Inc.
5580 Peterson Lane
Suite 120
Dallas, TX 75201
United States
800 497 6059
https://www.rtslco.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 3
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Donal R. Schmidt Jr. | President, CEO & Chairman | N/D | N/D | 1961 |
| Mr. D. Hughes Watler Jr. | CFO & Director | 37.62k | N/D | 1949 |
| Dr. Duane C. Drinkwine Ph.D. | Chief Science Officer | N/D | N/D | N/D |
| Mr. Ryan C. Johnson | Vice President of Marketing | N/D | N/D | 1975 |
| Mr. Frank Gill | Chief Isolate Laboratory Technician | N/D | N/D | N/D |
| Mr. Sean Paul Berrier | Senior Vice President | N/D | N/D | N/D |
Descripción
Rapid Therapeutic Science Laboratories, Inc. operates as a biotech company, provides natural based relief through aerosol delivery systems for non-psychoactive cannabinoids. The company was formerly known as Holly Brothers Pictures, Inc. and changed its name to Rapid Therapeutic Science Laboratories, Inc. in January 2020. Rapid Therapeutic Science Laboratories, Inc. was incorporated in 2013 and is based in Dallas, Texas.
Gestión corporativa
La calificación ISS Governance QuickScore de Rapid Therapeutic Science Laboratories, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
